Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG2, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Prezalumab Biosimilar - Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb - Research Grade |
|---|---|
| Source | CAS 1523164-68-2 |
| Species | Homo sapiens |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Prezalumab,AMG 557,MEDI-5872,ICOSLG, B7-H2, B7RP-1, CD275,anti-ICOSLG, B7-H2, B7RP-1, CD275 |
| Reference | PX-TA1417 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG2-kappa |
| Clonality | Monoclonal Antibody |
Prezalumab has been investigated for the treatment of Sjogren’s syndrome Cutaneous Lupus Erythematosus, Psoriasis, and Systemic Lupus Erythematosus (SLE).
Prezalumab Biosimilar - Anti-ICOSLG, B7-H2, B7RP-1, CD275 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.